Literature DB >> 20661748

Activity of the julocrotine, a glutarimide alkaloid from Croton pullei var. glabrior, on Leishmania (L.) amazonensis.

Leda R C Guimarães1, Ana Paula D Rodrigues, Patrícia S B Marinho, Adolfo H Muller, Giselle M S Guilhon, Lourivaldo S Santos, José Luiz M do Nascimento, Edilene O Silva.   

Abstract

The antiproliferative effect of julocrotine, an alkaloid isolated from Croton pullei var. glabrior (Euphorbiaceae), was studied in the macrophage amastigote and promastigote stages of the protozoan Leishmania (L.) amazonensis, which causes cutaneous leishmaniasis in the New World. Julocrotine showed a dose-dependent effect against the amastigote and promastigote forms, where 79 μM julocrotine inhibited promastigote growth by 54%, with an IC50 of 67 μM. To analyze the antiamastigote activity of the drug, murine peritoneal macrophages infected with L. amazonensis promastigotes were treated with different concentrations of julocrotine. An 80% inhibition of amastigote development was observed using 79 μM julocrotine for 72 h, with an IC50 of 19.8 μM. In addition, ultrastructural observation of the parasites showed a significant reduction in the number of amastigotes in the parasitophorous vacuoles and morphological changes in promastigotes, such as swelling of the mitochondrion, chromatin condensation, presence of membranous structures near the Golgi complex, and some vesicle bodies in the flagellar pocket. A colorimetric assay (MTT), which measures cytotoxic metabolic activity, showed that macrophages maintain their viability after treatment with the drug. These results suggest that julocrotine effectively inhibits the growth of parasites and does not have any cytototoxic effects on the host cell.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661748     DOI: 10.1007/s00436-010-1973-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  19 in total

1.  Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.

Authors:  E C Torres-Santos; D L Moreira; M A Kaplan; M N Meirelles; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

Authors:  Simon L Croft; Graham H Coombs
Journal:  Trends Parasitol       Date:  2003-11

3.  Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.

Authors:  Tatiana Shioji Tiuman; Tânia Ueda-Nakamura; Diógenes Aparício Garcia Cortez; Benedito Prado Dias Filho; José Andrés Morgado-Díaz; Wanderley de Souza; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Induction of apoptosis in human promyelocytic leukemia cells by a natural trachylobane diterpene.

Authors:  S Block; P Gerkens; O Peulen; O Jolois; M P Mingeot-Leclercq; M Cl De Pauw-Gillet; J Quetin-Leclercq
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

5.  Antileishmanial activity of an indole alkaloid from Peschiera australis.

Authors:  J C Delorenzi; M Attias; C R Gattass; M Andrade; C Rezende; A da Cunha Pinto ; A T Henriques; D C Bou-Habib; E M Saraiva
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

6.  Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis.

Authors:  Juliany C F Rodrigues; Márcia Attias; Carlos Rodriguez; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

7.  Anti-inflammatory activity of Croton cuneatus aqueous extract.

Authors:  Alírica I Suárez; Zuleyma Blanco; Reinaldo S Compagnone; María M Salazar-Bookaman; Varlin Zapata; Claudia Alvarado
Journal:  J Ethnopharmacol       Date:  2005-11-28       Impact factor: 4.360

8.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

Review 9.  Alkaloids: future prospective to combat leishmaniasis.

Authors:  Bhuwan B Mishra; Raju R Kale; Rakesh K Singh; Vinod K Tiwari
Journal:  Fitoterapia       Date:  2008-10-31       Impact factor: 2.882

10.  Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania.

Authors:  M A Vannier-Santos; J A Urbina; A Martiny; A Neves; W de Souza
Journal:  J Eukaryot Microbiol       Date:  1995 Jul-Aug       Impact factor: 3.346

View more
  12 in total

1.  Anti-malarial, anti-trypanosomal, and anti-leishmanial activities of jacaranone isolated from Pentacalia desiderabilis (Vell.) Cuatrec. (Asteraceae).

Authors:  Thiago R Morais; Paulete Romoff; Oriana A Fávero; Juliana Q Reimão; Walkyria C Lourenço; André G Tempone; Angelica D Hristov; Silvia M Di Santi; João Henrique G Lago; Patricia Sartorelli; Marcelo J P Ferreira
Journal:  Parasitol Res       Date:  2011-05-26       Impact factor: 2.289

2.  Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes.

Authors:  Sudipta Hazra; Subhalakshmi Ghosh; Sukalyani Debnath; Scott Seville; Vijay Kumar Prajapati; Colin W Wright; Shyam Sundar; Banasri Hazra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

Review 3.  Plant-derived compounds in treatment of leishmaniasis.

Authors:  A Oryan
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

Review 4.  Emerging therapeutic targets for treatment of leishmaniasis.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Opin Ther Targets       Date:  2018-05-09       Impact factor: 6.902

5.  Synthesis of (-)-julocrotine and a diversity oriented Ugi-approach to analogues and probes.

Authors:  Ricardo A W Neves Filho; Bernhard Westermann; Ludger A Wessjohann
Journal:  Beilstein J Org Chem       Date:  2011-11-07       Impact factor: 2.883

6.  In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.

Authors:  Carolina de Siqueira Paladi; Isabella Aparecida Salerno Pimentel; Simone Katz; Rodrigo L O R Cunha; Wagner Alves de Souza Judice; Antonio C F Caires; Clara Lúcia Barbiéri
Journal:  PLoS Negl Trop Dis       Date:  2012-05-15

Review 7.  Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

Authors:  Manar Ahmed Fouad; Hamida Abdel-Hamid; Mohammed Salah Ayoup
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

8.  In vitro biological action of aqueous extract from roots of Physalis angulata against Leishmania (Leishmania) amazonensis.

Authors:  Raquel Raick P da Silva; Bruno J M da Silva; Ana Paula D Rodrigues; Luis Henrique S Farias; Milton N da Silva; Danila Teresa V Alves; Gilmara N T Bastos; José Luiz M do Nascimento; Edilene O Silva
Journal:  BMC Complement Altern Med       Date:  2015-07-24       Impact factor: 3.659

Review 9.  The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.

Authors:  Patrick O Sakyi; Richard K Amewu; Robert N O A Devine; Emahi Ismaila; Whelton A Miller; Samuel K Kwofie
Journal:  Nat Prod Bioprospect       Date:  2021-07-14

10.  Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants.

Authors:  Fidele Ntie-Kang; Pascal Amoa Onguéné; Ghislain W Fotso; Kerstin Andrae-Marobela; Merhatibeb Bezabih; Jean Claude Ndom; Bonaventure T Ngadjui; Abiodun O Ogundaini; Berhanu M Abegaz; Luc Mbaze Meva'a
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.